+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Stem Cells Market by Type, Source, Application, End-user - Global Forecast 2025-2030- Product Image
Stem Cells Market by Type, Source, Application, End-user - Global Forecast 2025-2030- Product Image
Sale

Stem Cells Market by Type, Source, Application, End-user - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 197 Pages
  • October 2024
  • Region: Global
  • 360iResearch™
  • ID: 4857951
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Stem Cells Market grew from USD 13.66 billion in 2023 to USD 15.05 billion in 2024. It is expected to continue growing at a CAGR of 10.79%, reaching USD 27.99 billion by 2030.

Stem cells, characterized by their unique ability to develop into various cell types, are pivotal in regenerative medicine and have vast therapeutic potential. The scope of stem cell research includes their application in drug discovery, tissue regeneration, and the treatment of diseases such as Parkinson's, diabetes, and certain cancers. The necessity of stem cells lies in their potential to revolutionize medical treatments and improve patient outcomes significantly. Current applications span tissue and organ repair, where they can regenerate damaged cells, offering life-saving solutions. End-users primarily include academic institutions, pharmaceutical companies, and biotechnology firms engaged in research and clinical trials.

Market growth is driven by increased investment in healthcare R&D, rising prevalence of chronic diseases, and advancements in technology that facilitate stem cell research. Furthermore, regulatory approvals and increased collaboration between research institutions and businesses provide significant growth opportunities. The emergence of induced pluripotent stem cells (iPSCs) underscores a major technological breakthrough, offering potential in personalized medicine. However, challenges such as ethical concerns, high development costs, and stringent regulatory frameworks can hinder progress and expansion.

To capitalize on growth opportunities, companies should focus on developing less invasive stem cell therapies and expanding their application scope through strategic partnerships and investments in R&D. Addressing limitations involves engaging with regulatory bodies early in the development process to streamline approvals and enhance patient accessibility. A renewed focus on overcoming ethical and logistical barriers in clinical applications is critical.

Innovation can be pursued in areas such as optimizing cell reprogramming techniques and developing scalable manufacturing processes. Startups and established companies should explore synergies in adjacent fields like machine learning for predictive modeling in stem cell behavior, which may drive further innovation and competitive differentiation. The nature of the stem cell market is dynamic, marked by rapid advancements and a growing trend towards personalized medicine, suggesting that adaptability and innovation will be key to sustained growth and leadership in the industry.

Understanding Market Dynamics in the Stem Cells Market

The Stem Cells Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • Introduction of advanced Genome-based cell analysis techniques
    • Increasing investment in the development of stem cell therapies
    • Infrastructural development related to stem cell banking and processing
  • Market Restraints
    • High costs associated with stem cell therapies and lack of skilled personnel
  • Market Opportunities
    • Expansion of the therapeutic applications of iPSCs and advancements in 3D bioprinting using stem cells for tissue and organ regeneration
    • Growing applications of stem cells in personalized medicine
  • Market Challenges
    • Ethical issues surrounding embryonic stem cell research

Exploring Porter’s Five Forces for the Stem Cells Market

Porter’s Five Forces framework further strengthens the insights of the Stem Cells Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Stem Cells Market

External macro-environmental factors deeply influence the performance of the Stem Cells Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Stem Cells Market

The Stem Cells Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Stem Cells Market

The Stem Cells Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Stem Cells Market

The Stem Cells Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Stem Cells Market, highlighting leading vendors and their innovative profiles. These include Advanced Cell Technology, Inc., AlloSource, Inc., Anterogen Co., Ltd., Athersys Inc., Becton, Dickinson and Company, Bioheart Inc., Biorestorative Therapies Inc., BioTime, Inc., BrainStorm Cell Therapeutics Inc., Celgene Corporation, Cellartis AB, CellGenix GmbH, Cellular Engineering Technologies Inc., Gamida Cell Ltd, GenScript Biotech Corporation, Gilead Sciences, Inc., Holostem Terapie Avanzate Srl by Fondazione Enea Tech e Biomedical,, JCR Pharmaceuticals Co., Ltd., Lonza Group Ltd, Novartis AG, NuVasive Inc., Pluristyx, Inc., RTI Surgical, Takeda Pharmaceutical Company Limited, and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the Stem Cells Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Type
    • Adult Stem Cell
    • Human Embryonic Stem Cell
    • Induced Pluripotent Stem Cell
  • Source
    • Allogenic
    • Autologous
  • Application
    • Diagnostics
    • Drug Discovery & Development
    • Regenerative Medicines
      • Cardiology
      • Neurology
      • Oncology
  • End-user
    • Academic & Research Institutes
    • Hospitals & Cell Banks
    • Pharmaceutical & Biotechnology Companies
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  1. Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  2. Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  3. Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  4. Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  5. Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current size of the market, and how is it expected to grow?
  2. Which products, segments, and regions present the most attractive investment opportunities?
  3. What are the prevailing technology trends and regulatory factors influencing the market?
  4. How do top vendors rank regarding market share and competitive positioning?
  5. What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Introduction of advanced Genome-based cell analysis techniques
5.1.1.2. Increasing investment in the development of stem cell therapies
5.1.1.3. Infrastructural development related to stem cell banking and processing
5.1.2. Restraints
5.1.2.1. High costs associated with stem cell therapies and lack of skilled personnel
5.1.3. Opportunities
5.1.3.1. Expansion of the therapeutic applications of iPSCs and advancements in 3D bioprinting using stem cells for tissue and organ regeneration
5.1.3.2. Growing applications of stem cells in personalized medicine
5.1.4. Challenges
5.1.4.1. Ethical issues surrounding embryonic stem cell research
5.2. Market Segmentation Analysis
5.2.1. Type: Increasing usage of adult stem cells due to its fewer ethical and regulatory hurdles
5.2.2. Application: Expanding the application of stem cells in developing diagnostic models
5.3. Market Disruption Analysis
5.4. Porter’s Five Forces Analysis
5.4.1. Threat of New Entrants
5.4.2. Threat of Substitutes
5.4.3. Bargaining Power of Customers
5.4.4. Bargaining Power of Suppliers
5.4.5. Industry Rivalry
5.5. Value Chain & Critical Path Analysis
5.6. Pricing Analysis
5.7. Technology Analysis
5.8. Patent Analysis
5.9. Trade Analysis
5.10. Regulatory Framework Analysis
6. Stem Cells Market, by Type
6.1. Introduction
6.2. Adult Stem Cell
6.3. Human Embryonic Stem Cell
6.4. Induced Pluripotent Stem Cell
7. Stem Cells Market, by Source
7.1. Introduction
7.2. Allogenic
7.3. Autologous
8. Stem Cells Market, by Application
8.1. Introduction
8.2. Diagnostics
8.3. Drug Discovery & Development
8.4. Regenerative Medicines
9. Stem Cells Market, by End-user
9.1. Introduction
9.2. Academic & Research Institutes
9.3. Hospitals & Cell Banks
9.4. Pharmaceutical & Biotechnology Companies
10. Americas Stem Cells Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Stem Cells Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Stem Cells Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. Market Share Analysis, 2023
13.2. FPNV Positioning Matrix, 2023
13.3. Competitive Scenario Analysis
13.3.1. QHP Capital Acquires Applied StemCell
13.3.2. Stem Genomics, Pluristyx Partner for Pluripotent Stem Cell Products, Services
13.3.3. denovoMATRIX Expands its Product Portfolio by Launching its First Stem Cell Product
13.4. Strategy Analysis & Recommendation
14. Competitive Portfolio
14.1. Key Company Profiles
14.2. Key Product Portfolio
List of Figures
FIGURE 1. STEM CELLS MARKET RESEARCH PROCESS
FIGURE 2. STEM CELLS MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL STEM CELLS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL STEM CELLS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. GLOBAL STEM CELLS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. STEM CELLS MARKET DYNAMICS
FIGURE 7. GLOBAL STEM CELLS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
FIGURE 8. GLOBAL STEM CELLS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL STEM CELLS MARKET SIZE, BY SOURCE, 2023 VS 2030 (%)
FIGURE 10. GLOBAL STEM CELLS MARKET SIZE, BY SOURCE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL STEM CELLS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 12. GLOBAL STEM CELLS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL STEM CELLS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 14. GLOBAL STEM CELLS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS STEM CELLS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. AMERICAS STEM CELLS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES STEM CELLS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 18. UNITED STATES STEM CELLS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC STEM CELLS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC STEM CELLS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA STEM CELLS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA STEM CELLS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. STEM CELLS MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 24. STEM CELLS MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. STEM CELLS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL STEM CELLS MARKET SIZE, 2018-2023 (USD MILLION)
TABLE 4. GLOBAL STEM CELLS MARKET SIZE, 2024-2030 (USD MILLION)
TABLE 5. GLOBAL STEM CELLS MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
TABLE 6. GLOBAL STEM CELLS MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
TABLE 7. GLOBAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 8. GLOBAL STEM CELLS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 9. GLOBAL STEM CELLS MARKET SIZE, BY ADULT STEM CELL, BY REGION, 2018-2023 (USD MILLION)
TABLE 10. GLOBAL STEM CELLS MARKET SIZE, BY ADULT STEM CELL, BY REGION, 2024-2030 (USD MILLION)
TABLE 11. GLOBAL STEM CELLS MARKET SIZE, BY HUMAN EMBRYONIC STEM CELL, BY REGION, 2018-2023 (USD MILLION)
TABLE 12. GLOBAL STEM CELLS MARKET SIZE, BY HUMAN EMBRYONIC STEM CELL, BY REGION, 2024-2030 (USD MILLION)
TABLE 13. GLOBAL STEM CELLS MARKET SIZE, BY INDUCED PLURIPOTENT STEM CELL, BY REGION, 2018-2023 (USD MILLION)
TABLE 14. GLOBAL STEM CELLS MARKET SIZE, BY INDUCED PLURIPOTENT STEM CELL, BY REGION, 2024-2030 (USD MILLION)
TABLE 15. GLOBAL STEM CELLS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 16. GLOBAL STEM CELLS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 17. GLOBAL STEM CELLS MARKET SIZE, BY ALLOGENIC, BY REGION, 2018-2023 (USD MILLION)
TABLE 18. GLOBAL STEM CELLS MARKET SIZE, BY ALLOGENIC, BY REGION, 2024-2030 (USD MILLION)
TABLE 19. GLOBAL STEM CELLS MARKET SIZE, BY AUTOLOGOUS, BY REGION, 2018-2023 (USD MILLION)
TABLE 20. GLOBAL STEM CELLS MARKET SIZE, BY AUTOLOGOUS, BY REGION, 2024-2030 (USD MILLION)
TABLE 21. GLOBAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 22. GLOBAL STEM CELLS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 23. GLOBAL STEM CELLS MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2023 (USD MILLION)
TABLE 24. GLOBAL STEM CELLS MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2024-2030 (USD MILLION)
TABLE 25. GLOBAL STEM CELLS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2018-2023 (USD MILLION)
TABLE 26. GLOBAL STEM CELLS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2024-2030 (USD MILLION)
TABLE 27. GLOBAL STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, BY REGION, 2018-2023 (USD MILLION)
TABLE 28. GLOBAL STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, BY REGION, 2024-2030 (USD MILLION)
TABLE 29. GLOBAL STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2018-2023 (USD MILLION)
TABLE 30. GLOBAL STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2024-2030 (USD MILLION)
TABLE 31. GLOBAL STEM CELLS MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2023 (USD MILLION)
TABLE 32. GLOBAL STEM CELLS MARKET SIZE, BY CARDIOLOGY, BY REGION, 2024-2030 (USD MILLION)
TABLE 33. GLOBAL STEM CELLS MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2023 (USD MILLION)
TABLE 34. GLOBAL STEM CELLS MARKET SIZE, BY NEUROLOGY, BY REGION, 2024-2030 (USD MILLION)
TABLE 35. GLOBAL STEM CELLS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2023 (USD MILLION)
TABLE 36. GLOBAL STEM CELLS MARKET SIZE, BY ONCOLOGY, BY REGION, 2024-2030 (USD MILLION)
TABLE 37. GLOBAL STEM CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 38. GLOBAL STEM CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 39. GLOBAL STEM CELLS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2023 (USD MILLION)
TABLE 40. GLOBAL STEM CELLS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2024-2030 (USD MILLION)
TABLE 41. GLOBAL STEM CELLS MARKET SIZE, BY HOSPITALS & CELL BANKS, BY REGION, 2018-2023 (USD MILLION)
TABLE 42. GLOBAL STEM CELLS MARKET SIZE, BY HOSPITALS & CELL BANKS, BY REGION, 2024-2030 (USD MILLION)
TABLE 43. GLOBAL STEM CELLS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2023 (USD MILLION)
TABLE 44. GLOBAL STEM CELLS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2024-2030 (USD MILLION)
TABLE 45. AMERICAS STEM CELLS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 46. AMERICAS STEM CELLS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 47. AMERICAS STEM CELLS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 48. AMERICAS STEM CELLS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 49. AMERICAS STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 50. AMERICAS STEM CELLS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 51. AMERICAS STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2018-2023 (USD MILLION)
TABLE 52. AMERICAS STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2024-2030 (USD MILLION)
TABLE 53. AMERICAS STEM CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 54. AMERICAS STEM CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 55. AMERICAS STEM CELLS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 56. AMERICAS STEM CELLS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 57. ARGENTINA STEM CELLS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 58. ARGENTINA STEM CELLS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 59. ARGENTINA STEM CELLS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 60. ARGENTINA STEM CELLS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 61. ARGENTINA STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 62. ARGENTINA STEM CELLS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 63. ARGENTINA STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2018-2023 (USD MILLION)
TABLE 64. ARGENTINA STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2024-2030 (USD MILLION)
TABLE 65. ARGENTINA STEM CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 66. ARGENTINA STEM CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 67. BRAZIL STEM CELLS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 68. BRAZIL STEM CELLS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 69. BRAZIL STEM CELLS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 70. BRAZIL STEM CELLS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 71. BRAZIL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 72. BRAZIL STEM CELLS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 73. BRAZIL STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2018-2023 (USD MILLION)
TABLE 74. BRAZIL STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2024-2030 (USD MILLION)
TABLE 75. BRAZIL STEM CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 76. BRAZIL STEM CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 77. CANADA STEM CELLS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 78. CANADA STEM CELLS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 79. CANADA STEM CELLS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 80. CANADA STEM CELLS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 81. CANADA STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 82. CANADA STEM CELLS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 83. CANADA STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2018-2023 (USD MILLION)
TABLE 84. CANADA STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2024-2030 (USD MILLION)
TABLE 85. CANADA STEM CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 86. CANADA STEM CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 87. MEXICO STEM CELLS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 88. MEXICO STEM CELLS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 89. MEXICO STEM CELLS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 90. MEXICO STEM CELLS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 91. MEXICO STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 92. MEXICO STEM CELLS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 93. MEXICO STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2018-2023 (USD MILLION)
TABLE 94. MEXICO STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2024-2030 (USD MILLION)
TABLE 95. MEXICO STEM CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 96. MEXICO STEM CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 97. UNITED STATES STEM CELLS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 98. UNITED STATES STEM CELLS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 99. UNITED STATES STEM CELLS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 100. UNITED STATES STEM CELLS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 101. UNITED STATES STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 102. UNITED STATES STEM CELLS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 103. UNITED STATES STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2018-2023 (USD MILLION)
TABLE 104. UNITED STATES STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2024-2030 (USD MILLION)
TABLE 105. UNITED STATES STEM CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 106. UNITED STATES STEM CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 107. UNITED STATES STEM CELLS MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
TABLE 108. UNITED STATES STEM CELLS MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
TABLE 109. ASIA-PACIFIC STEM CELLS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 110. ASIA-PACIFIC STEM CELLS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 111. ASIA-PACIFIC STEM CELLS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 112. ASIA-PACIFIC STEM CELLS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 113. ASIA-PACIFIC STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 114. ASIA-PACIFIC STEM CELLS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 115. ASIA-PACIFIC STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2018-2023 (USD MILLION)
TABLE 116. ASIA-PACIFIC STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2024-2030 (USD MILLION)
TABLE 117. ASIA-PACIFIC STEM CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 118. ASIA-PACIFIC STEM CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 119. ASIA-PACIFIC STEM CELLS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 120. ASIA-PACIFIC STEM CELLS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 121. AUSTRALIA STEM CELLS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 122. AUSTRALIA STEM CELLS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 123. AUSTRALIA STEM CELLS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 124. AUSTRALIA STEM CELLS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 125. AUSTRALIA STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 126. AUSTRALIA STEM CELLS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 127. AUSTRALIA STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2018-2023 (USD MILLION)
TABLE 128. AUSTRALIA STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2024-2030 (USD MILLION)
TABLE 129. AUSTRALIA STEM CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 130. AUSTRALIA STEM CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 131. CHINA STEM CELLS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 132. CHINA STEM CELLS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 133. CHINA STEM CELLS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 134. CHINA STEM CELLS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 135. CHINA STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 136. CHINA STEM CELLS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 137. CHINA STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2018-2023 (USD MILLION)
TABLE 138. CHINA STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2024-2030 (USD MILLION)
TABLE 139. CHINA STEM CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 140. CHINA STEM CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 141. INDIA STEM CELLS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 142. INDIA STEM CELLS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 143. INDIA STEM CELLS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 144. INDIA STEM CELLS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 145. INDIA STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 146. INDIA STEM CELLS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 147. INDIA STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2018-2023 (USD MILLION)
TABLE 148. INDIA STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2024-2030 (USD MILLION)
TABLE 149. INDIA STEM CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 150. INDIA STEM CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 151. INDONESIA STEM CELLS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 152. INDONESIA STEM CELLS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 153. INDONESIA STEM CELLS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 154. INDONESIA STEM CELLS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 155. INDONESIA STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 156. INDONESIA STEM CELLS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 157. INDONESIA STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2018-2023 (USD MILLION)
TABLE 158. INDONESIA STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2024-2030 (USD MILLION)
TABLE 159. INDONESIA STEM CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 160. INDONESIA STEM CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 161. JAPAN STEM CELLS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 162. JAPAN STEM CELLS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 163. JAPAN STEM CELLS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 164. JAPAN STEM CELLS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 165. JAPAN STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 166. JAPAN STEM CELLS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 167. JAPAN STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2018-2023 (USD MILLION)
TABLE 168. JAPAN STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2024-2030 (USD MILLION)
TABLE 169. JAPAN STEM CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 170. JAPAN STEM CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 171. MALAYSIA STEM CELLS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 172. MALAYSIA STEM CELLS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 173. MALAYSIA STEM CELLS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 174. MALAYSIA STEM CELLS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 175. MALAYSIA STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 176. MALAYSIA STEM CELLS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 177. MALAYSIA STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2018-2023 (USD MILLION)
TABLE 178. MALAYSIA STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2024-2030 (USD MILLION)
TABLE 179. MALAYSIA STEM CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 180. MALAYSIA STEM CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 181. PHILIPPINES STEM CELLS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 182. PHILIPPINES STEM CELLS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 183. PHILIPPINES STEM CELLS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 184. PHILIPPINES STEM CELLS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 185. PHILIPPINES STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 186. PHILIPPINES STEM CELLS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 187. PHILIPPINES STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2018-2023 (USD MILLION)
TABLE 188. PHILIPPINES STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2024-2030 (USD MILLION)
TABLE 189. PHILIPPINES STEM CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 190. PHILIPPINES STEM CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 191. SINGAPORE STEM CELLS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 192. SINGAPORE STEM CELLS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 193. SINGAPORE STEM CELLS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 194. SINGAPORE STEM CELLS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 195. SINGAPORE STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 196. SINGAPORE STEM CELLS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 197. SINGAPORE STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2018-2023 (USD MILLION)
TABLE 198. SINGAPORE STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2024-2030 (USD MILLION)
TABLE 199. SINGAPORE STEM CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 200. SINGAPORE STEM CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 201. SOUTH KOREA STEM CELLS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 202. SOUTH KOREA STEM CELLS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 203. SOUTH KOREA STEM CELLS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 204. SOUTH KOREA STEM CELLS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 205. SOUTH KOREA STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 206. SOUTH KOREA STEM CELLS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 207. SOUTH KOREA STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2018-2023 (USD MILLION)
TABLE 208. SOUTH KOREA STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2024-2030 (USD MILLION)
TABLE 209. SOUTH KOREA STEM CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 210. SOUTH KOREA STEM CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 211. TAIWAN STEM CELLS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 212. TAIWAN STEM CELLS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 213. TAIWAN STEM CELLS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 214. TAIWAN STEM CELLS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 215. TAIWAN STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 216. TAIWAN STEM CELLS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 217. TAIWAN STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2018-2023 (USD MILLION)
TABLE 218. TAIWAN STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2024-2030 (USD MILLION)
TABLE 219. TAIWAN STEM CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 220. TAIWAN STEM CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 221. THAILAND STEM CELLS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 222. THAILAND STEM CELLS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 223. THAILAND STEM CELLS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 224. THAILAND STEM CELLS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 225. THAILAND STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 226. THAILAND STEM CELLS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 227. THAILAND STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2018-2023 (USD MILLION)
TABLE 228. THAILAND STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2024-2030 (USD MILLION)
TABLE 229. THAILAND STEM CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 230. THAILAND STEM CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 231. VIETNAM STEM CELLS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 232. VIETNAM STEM CELLS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 233. VIETNAM STEM CELLS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 234. VIETNAM STEM CELLS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 235. VIETNAM STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 236. VIETNAM STEM CELLS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 237. VIETNAM STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2018-2023 (USD MILLION)
TABLE 238. VIETNAM STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2024-2030 (USD MILLION)
TABLE 239. VIETNAM STEM CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 240. VIETNAM STEM CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 241. EUROPE, MIDDLE EAST & AFRICA STEM CELLS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 242. EUROPE, MIDDLE EAST & AFRICA STEM CELLS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 243. EUROPE, MIDDLE EAST & AFRICA STEM CELLS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 244. EUROPE, MIDDLE EAST & AFRICA STEM CELLS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 245. EUROPE, MIDDLE EAST & AFRICA STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 246. EUROPE, MIDDLE EAST & AFRICA STEM CELLS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 247. EUROPE, MIDDLE EAST & AFRICA STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2018-2023 (USD MILLION)
TABLE 248. EUROPE, MIDDLE EAST & AFRICA STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2024-2030 (USD MILLION)
TABLE 249. EUROPE, MIDDLE EAST & AFRICA STEM CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 250. EUROPE, MIDDLE EAST & AFRICA STEM CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 251. EUROPE, MIDDLE EAST & AFRICA STEM CELLS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 252. EUROPE, MIDDLE EAST & AFRICA STEM CELLS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 253. DENMARK STEM CELLS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 254. DENMARK STEM CELLS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 255. DENMARK STEM CELLS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 256. DENMARK STEM CELLS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 257. DENMARK STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 258. DENMARK STEM CELLS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 259. DENMARK STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2018-2023 (USD MILLION)
TABLE 260. DENMARK STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2024-2030 (USD MILLION)
TABLE 261. DENMARK STEM CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 262. DENMARK STEM CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 263. EGYPT STEM CELLS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 264. EGYPT STEM CELLS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 265. EGYPT STEM CELLS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 266. EGYPT STEM CELLS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 267. EGYPT STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 268. EGYPT STEM CELLS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 269. EGYPT STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2018-2023 (USD MILLION)
TABLE 270. EGYPT STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2024-2030 (USD MILLION)
TABLE 271. EGYPT STEM CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 272. EGYPT STEM CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 273. FINLAND STEM CELLS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 274. FINLAND STEM CELLS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 275. FINLAND STEM CELLS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 276. FINLAND STEM CELLS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 277. FINLAND STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 278. FINLAND STEM CELLS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 279. FINLAND STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2018-2023 (USD MILLION)
TABLE 280. FINLAND STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2024-2030 (USD MILLION)
TABLE 281. FINLAND STEM CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 282. FINLAND STEM CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 283. FRANCE STEM CELLS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 284. FRANCE STEM CELLS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 285. FRANCE STEM CELLS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 286. FRANCE STEM CELLS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 287. FRANCE STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 288. FRANCE STEM CELLS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 289. FRANCE STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2018-2023 (USD MILLION)
TABLE 290. FRANCE STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2024-2030 (USD MILLION)
TABLE 291. FRANCE STEM CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 292. FRANCE STEM CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 293. GERMANY STEM CELLS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 294. GERMANY STEM CELLS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 295. GERMANY STEM CELLS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 296. GERMANY STEM CELLS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 297. GERMANY STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 298. GERMANY STEM CELLS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 299. GERMANY STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2018-2023 (USD MILLION)
TABLE 300. GERMANY STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2024-2030 (USD MILLION)
TABLE 301. GERMANY STEM CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 302. GERMANY STEM CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 303. ISRAEL STEM CELLS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 304. ISRAEL STEM CELLS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 305. ISRAEL STEM CELLS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 306. ISRAEL STEM CELLS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 307. ISRAEL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 308. ISRAEL STEM CELLS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 309. ISRAEL STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2018-2023 (USD MILLION)
TABLE 310. ISRAEL STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2024-2030 (USD MILLION)
TABLE 311. ISRAEL STEM CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 312. ISRAEL STEM CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 313. ITALY STEM CELLS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 314. ITALY STEM CELLS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 315. ITALY STEM CELLS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 316. ITALY STEM CELLS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 317. ITALY STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 318. ITALY STEM CELLS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 319. ITALY STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2018-2023 (USD MILLION)
TABLE 320. ITALY STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2024-2030 (USD MILLION)
TABLE 321. ITALY STEM CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 322. ITALY STEM CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 323. NETHERLANDS STEM CELLS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 324. NETHERLANDS STEM CELLS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 325. NETHERLANDS STEM CELLS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 326. NETHERLANDS STEM CELLS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 327. NETHERLANDS STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 328. NETHERLANDS STEM CELLS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 329. NETHERLANDS STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2018-2023 (USD MILLION)
TABLE 330. NETHERLANDS STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2024-2030 (USD MILLION)
TABLE 331. NETHERLANDS STEM CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 332. NETHERLANDS STEM CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 333. NIGERIA STEM CELLS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 334. NIGERIA STEM CELLS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 335. NIGERIA STEM CELLS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 336. NIGERIA STEM CELLS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 337. NIGERIA STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 338. NIGERIA STEM CELLS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 339. NIGERIA STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2018-2023 (USD MILLION)
TABLE 340. NIGERIA STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2024-2030 (USD MILLION)
TABLE 341. NIGERIA STEM CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 342. NIGERIA STEM CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 343. NORWAY STEM CELLS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 344. NORWAY STEM CELLS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 345. NORWAY STEM CELLS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 346. NORWAY STEM CELLS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 347. NORWAY STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 348. NORWAY STEM CELLS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 349. NORWAY STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2018-2023 (USD MILLION)
TABLE 350. NORWAY STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2024-2030 (USD MILLION)
TABLE 351. NORWAY STEM CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 352. NORWAY STEM CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 353. POLAND STEM CELLS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 354. POLAND STEM CELLS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 355. POLAND STEM CELLS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 356. POLAND STEM CELLS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 357. POLAND STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 358. POLAND STEM CELLS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 359. POLAND STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2018-2023 (USD MILLION)
TABLE 360. POLAND STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2024-2030 (USD MILLION)
TABLE 361. POLAND STEM CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 362. POLAND STEM CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 363. QATAR STEM CELLS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 364. QATAR STEM CELLS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 365. QATAR STEM CELLS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 366. QATAR STEM CELLS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 367. QATAR STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 368. QATAR STEM CELLS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 369. QATAR STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2018-2023 (USD MILLION)
TABLE 370. QATAR STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2024-2030 (USD MILLION)
TABLE 371. QATAR STEM CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 372. QATAR STEM CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 373. RUSSIA STEM CELLS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 374. RUSSIA STEM CELLS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 375. RUSSIA STEM CELLS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 376. RUSSIA STEM CELLS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 377. RUSSIA STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 378. RUSSIA STEM CELLS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 379. RUSSIA STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2018-2023 (USD MILLION)
TABLE 380. RUSSIA STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2024-2030 (USD MILLION)
TABLE 381. RUSSIA STEM CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 382. RUSSIA STEM CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 383. SAUDI ARABIA STEM CELLS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 384. SAUDI ARABIA STEM CELLS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 385. SAUDI ARABIA STEM CELLS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 386. SAUDI ARABIA STEM CELLS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 387. SAUDI ARABIA STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 388. SAUDI ARABIA STEM CELLS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 389. SAUDI ARABIA STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2018-2023 (USD MILLION)
TABLE 390. SAUDI ARABIA STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICI

Companies Mentioned

The leading players in the Stem Cells market, which are profiled in this report, include:
  • Advanced Cell Technology, Inc.
  • AlloSource, Inc.
  • Anterogen Co., Ltd.
  • Athersys Inc.
  • Becton, Dickinson and Company
  • Bioheart Inc.
  • Biorestorative Therapies Inc.
  • BioTime, Inc.
  • BrainStorm Cell Therapeutics Inc.
  • Celgene Corporation
  • Cellartis AB
  • CellGenix GmbH
  • Cellular Engineering Technologies Inc.
  • Gamida Cell Ltd
  • GenScript Biotech Corporation
  • Gilead Sciences, Inc.
  • Holostem Terapie Avanzate Srl by Fondazione Enea Tech e Biomedical,
  • JCR Pharmaceuticals Co., Ltd.
  • Lonza Group Ltd
  • Novartis AG
  • NuVasive Inc.
  • Pluristyx, Inc.
  • RTI Surgical
  • Takeda Pharmaceutical Company Limited
  • Thermo Fisher Scientific Inc.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages197
PublishedOctober 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 15.05 Billion
Forecasted Market Value ( USD ) by 2030 $ 27.99 Billion
Compound Annual Growth Rate10.7%
Regions CoveredGlobal
No. of Companies Mentioned26

Related Topics

Related Reports

Stem Cells - Global Strategic Business Report - Product Image

Stem Cells - Global Strategic Business Report

  • Report
  • 369 Pages
  • Global
From
Human Embryonic Stem Cells Market by Type, Application, End-User - Global Forecast 2025-2030 - Product Image

Human Embryonic Stem Cells Market by Type, Application, End-User - Global Forecast 2025-2030

  • Report
  • 198 Pages
  • Global
From
Stem Cell Therapy Market by Type, Cell Source, Therapeutic Application, End-User - Global Forecast 2025-2030 - Product Image

Stem Cell Therapy Market by Type, Cell Source, Therapeutic Application, End-User - Global Forecast 2025-2030

  • Report
  • 192 Pages
  • Global
From
Stem Cells Market Size, Share & Trends Analysis Report by Product (Adult Stem Cells, Human Embryonic Stem Cells), Application (Regenerative Medicine), Technology, Therapy, End-use, Region, and Segment Forecasts, 2025-2030 - Product Image

Stem Cells Market Size, Share & Trends Analysis Report by Product (Adult Stem Cells, Human Embryonic Stem Cells), Application (Regenerative Medicine), Technology, Therapy, End-use, Region, and Segment Forecasts, 2025-2030

  • Report
  • 150 Pages
  • Global
From
Induced Pluripotent Stem Cells Production Market Size, Share & Trends Analysis Report By Process, By Workflow (Reprogramming, Cell Culture), By Product, By Application (Regenerative Medicine), By End-use, By Region, And Segment Forecasts, 2024 - 2030 - Product Image

Induced Pluripotent Stem Cells Production Market Size, Share & Trends Analysis Report By Process, By Workflow (Reprogramming, Cell Culture), By Product, By Application (Regenerative Medicine), By End-use, By Region, And Segment Forecasts, 2024 - 2030

  • Report
  • 120 Pages
  • Global
From

About the Stem Cells Market

The Stem Cells market is a rapidly growing industry that focuses on the use of stem cells for medical treatments and research. Stem cells are cells that have the potential to develop into many different types of cells in the body. They can be used to replace or repair damaged tissue, and can be used to treat a variety of diseases and conditions. Stem cell research has been ongoing for decades, and the potential for medical treatments is vast. Companies in the Stem Cells market are focused on developing treatments and therapies that use stem cells to treat a variety of diseases and conditions. These companies are also researching ways to use stem cells to create new organs and tissues for transplantation. Some of the major companies in the Stem Cells market include Celgene, Novartis, and Regeneron. These companies are focused on developing treatments and therapies that use stem cells to treat a variety of diseases and conditions. Other companies in the market include BioTime, Osiris Therapeutics, and Vericel Corporation. These companies are focused on developing treatments and therapies that use stem cells to treat a variety of diseases and conditions. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.